Polyrizon Ltd. Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions today announced positive results from ...

Alumis is firmly in focus after announcing positive topline results from two Phase 3 trials (ONWARD1 and ONWARD2) evaluating envudeucitinib , its next-generation oral TYK2 inhibitor, in ...

The Maternal Care Bundle (MCB) sets best practice standards across 5 areas of clinical care, for implementation by NHS providers and commissioners across England. The aim is to reduce maternal ...

As the flagship oncology journal under Sage Publishing, TAMO strives to publish research of significant value to oncology research and clinical practice. It covers clinical trials and real-world ...

Rezdiffra FDA approval fuels sales; expansion to F4 MASH cirrhosis with 2027 trial data. Read more about MDGL stock here.

Routine echocardiography in cancer centers can spot severe valve disease earlier and trigger timely treatment decisions.

Optune Lua adoption lag hit shares, but 2026 catalysts and $230M net cash could drive a rebound. Know more about NVCR stock ...

When women target other women, the damage runs deep. Female doctors open up about rivalry and exclusion that harm careers and ...

A Viewpoint published in Genomic Psychiatry examines how Brazil's extraordinary genetic diversity creates unparalleled ...

People with atrial fibrillation (AFib) and obesity may have fewer episodes of AFib after ablation if they take the diabetes ...

This, of course, isn’t Trump’s first time in office, nor is it his first attempt to manipulate, ignore, or erase the numbers.

HHS Secretary Robert F. Kennedy Jr.s CDC just funneled a $1.6 million dollar grant to researchers to carry out an unethical and scientifically unjustified randomized clinical trial of the birth dose o ...